IFN-α1 plasmid construct affords protection against HSV-1 infection in transfected L929 fibroblasts

Journal of Interferon and Cytokine Research

Volumn 20, Issue 1, 2000, Pages 107-115

  Noisakran, Sansanee ^a   Campbell, Iain L ^b   Carr, Daniel J J ^c  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON A; BETA GALACTOSIDASE; BETA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERFERON ANTIBODY; INTERFERON REGULATORY FACTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PLASMID DNA; 2',5' OLIGOADENYLATE SYNTHETASE; DNA BINDING PROTEIN; H2 ANTIGEN; IRF1 PROTEIN, MOUSE; PHOSPHOPROTEIN;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; VIRUS GENE; VIRUS INFECTION; VIRUS LOAD; VIRUS RESISTANCE; ANIMAL; BIOSYNTHESIS; CELL LINE; CERCOPITHECUS; DRUG EFFECT; GENE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HERPES SIMPLEX VIRUS; ISOLATION AND PURIFICATION; L CELL; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS REPLICATION;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, VIRAL; GENES, MHC CLASS I; GENETIC VECTORS; GTP-BINDING PROTEINS; H-2 ANTIGENS; INTERFERON REGULATORY FACTOR-1; INTERFERON-ALPHA; L CELLS (CELL LINE); MICE; PHOSPHOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIMPLEXVIRUS; TRANSFECTION; VIRUS REPLICATION;

EID: 0033622025     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000312784     Document Type: Article

References (39)

1. ROIZMAN, B., and SEARS, A.E. (1996). Herpes simples viruses and their replication. In: Fields Virology, 3rd ed. B. N. Fields, D. M. Knipe, and P. M. Howley (eds.) Philadelphia: Lippincott-Raven Publishers, 2231-2295.
2. SU, Y., YAN, X., OAKES, J.E., and LAUSCH, R.N. (1996). Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. J. Virol. 70, 1277-1281.
3. SHIMELD, C., WHITELAND, J.L., WILLIAMS, N.A., EASTY, D.L., and HILL, T.J. (1997). Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J. Gen. Virol. 78, 3317-3325.
4. BRANDT, C.R., and SALKOWSKI, C.A. (1992). Activation of NK cells in mice following corneal infection with herpes simplex virus type-1. Invest. Ophthalmol. Vis. Sci. 33, 113-120.
5. WELSH, R.M., and SEN, G.C. (1997). Nonspecific host responses to viral infections. In: Viral Pathogenesis. N. Nathanson (ed.) Philadelphia: Lippincott-Raven Publishers, pp. 109-141.
6. + T-cells. Biochem. Soc. Trans. 25, 687-690.
7. GUTTERMAN, J.U. (1994). Cytokine therapeutics: lessons from interferon α. Proc. Natl. Acad. Sci. USA 91, 1198-1205.
8. FOSTER, G.R. (1997). Interferons in host defense. Semin. Liver Dis. 17, 287-295.
9. DAHESHIA, M., KUKLIN, N., KANANGAT, S., MANICKAN, E., and ROUSE, B.T. (1997). Suppression of ongoing oculars inflammatory disease by topical administration of plasmid DNA encoding IL-10. J. Immunol. 159, 1945-1952.
10. CHUN, S., DAHESHIA, M., KUKLIN, N.A., and ROUSE, B.T. (1998). Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routes. J. Virol. 72, 5545-5551.
11. YEOW, W., LAWSON, C.M., and BEILHARZ, M.W. (1998). Antiviral activities of individual murine IFN-α subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication. J. Immunol. 160, 2932-2939.
12. NOISAKRAN, S., CAMPBELL, I.L., and CARR, D.J.J. (1999). Ectopic expression of DNA encoding IFN-α1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis. J. Immunol. 162, 4184-4190.
13. LEIBSON, P.J., HUNTER-LASZLO, M., and HAYWARD, A.R. (1986). Inhibition of herpes simplex virus type 1 replication in fibroblast cultures by human blood mononuclear cells. J. Virol. 57, 976-982.
14. BALISH, M., ABRAMS, M.E., PUMFERY, A.M., and BRANDT, C.R. (1992). Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-α and -γ. J. Infect. Dis. 166, 1401-1403.
15. CHATTERJEE, S., HUNTER E, and WHITLEY, R. (1985). Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus. J. Virol. 56, 419-425.
16. HALFORD, W.P., BEGHARDT, B.M., and CARR, D.J.J. (1996). Persistent cytokine expression on trigeminal ganglion latently infected with herpes virus type 1. J. Immunol. 157, 3542-3549.
17. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, pp. 1.42-1.45.
18. ASENSIO, V.C., and CAMPBELL, I.L. (1997). Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J. Virol. 71, 7832-7840.
19. TANAKA, H., and SAMUEL, C.E. (1995t). Sequence of the murine interferon-inducible RNA-dependent protein kinase (PKR) deduced from genomic clones. Gene 153, 283-284.
20. STALDER, A., PAGENSTECHER, A., KINCAID, C., and CAMPBELL, I.L. (1999). Analysis of gene expression by multi-probe RNase protection assay. In: Methods in Molecular Medicine. Neurodegeneration Methods and Protocols. J. Harry and H.A. Tilson (eds.) Totowa, NJ: Humana Press, pp. 63-66.
21. DUDOV, K.P., and PERRY R.P. (1984). The gene family encoding the mouse ribosomal protein L32 contains a uniquely expressed intron-containing gene and an unmutated processed gene. Cell 37, 457-468.
22. CARR, D.J.J., GEBHARDt, B.M., and PAUL, D. (1993). Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J. Pharmacol. Exp. Ther. 264, 1179-1186.
23. FITZGERALD-BOCARSLY, P., HOWELL, D.M., PETTERA, L., and TEHRANI, S. (1991). Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts. J. Virol. 65, 3151-3160.
24. SHIRAYOSHI, Y., BURKE, P.A., APPELLA, E., and OZATO, K. (1988). Interferon induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence. Proc. Natl. Acad. Sci. USA 85, 5884-5888.
25. OBERMAN, F., and PANET, A. (1988). Inhibition of transcription of herpes simplex virus immediate-early genes in interferon-treated human cells. J. Gen. Virol. 69, 1167-1177.
26. MITTNACHT, S., STRAUB P., KIRCHNER, H., and JACOBSEN, H. (1988). Interferon inhibits onset of herpes simplex virus immediate-early transcription. Virology 164, 201-210.
27. DOMKE, I., STRAUB, P., JACOBSEN, H., KIRCHNER, H., and PARET, A. (1985). Inhibition of replication of herpes simplex virus in mouse macrophages by interferons. J. Gen. Virol. 66, 2231-2236.
28. DOMKE, I., STRAUB, P., and KIRCHNER, H. (1986). Effect of interferon on replication of herpes simplex virus type 1 and 2 in human macrophages. J. Virol. 60, 37-42.
29. STAUB, P., DOMKE, I., KIRCHNER, H., JACOBSEN, H., and PANET, A. (1986). Synthesis of herpes simplex virus proteins and nucleic acids in interferon-treated macrophages. Virology 150, 411-418.
30. MUNOZ, A., and CARRASCO, L. (1984). Formation of non-infective herpesvirus particles in cultured cells treated with human interferon. J. Gen. Virol. 65, 1069-1078.
31. CHATTERJEE, S., LAKEMAN, A.D., WHITNEY, R.J., and HUNTER, E. (1984). Effect of cloned human interferons on the replication of and cell fusion induced by herpes simplex virus. Virus Res. 1, 81-87.
32. VILCEK, J., and SERR, G.C. (1996). Interferons and other cytokines. In: Fields Virology, 3rd ed. B. N. Fields, D. M. Knipe, and P. M. Howley (eds.) Philadelphia: Lippincott-Raven Publishers, pp. 375-399.
33. KAMIJO, R., HARADA, H., MATSUYAMA, T., BOSLAND, M., GERECITANA, J., SHAPIRO, D., LE, J., KOH, S.I., KIMURA, T., and GREEN, S.J. (1994). Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263, 1612-1615.
34. KODUKULA, P., LIU, T., ROOIJEN, N.V., JAGER, M.J., and HENDRICKS, R.L. (1999). Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J. Immunol. 162, 2895-2905.
35. TAL-SINGER, R., PODRZUCKI, W., LASNER, T.M., SKOKOTAS, A., LEARY, J.J., FRASER, N.W., and BERGER, S.L. (1998). Use of differential display reverse transcription-PCR to reveal cellular changes during stimuli that result in herpes simplex virus type 1 reactivation from latency: upregulation of immediate-early cellular response genes TIS7, interferon, and interferon regulatory factor-1. J. Virol. 72, 1252-1261.
36. TAYLOR, J.L., WITT, P.L., IRIZARRY, A., TOM, P., and O'BRIEN, W.J. (1995). 2′, 5′-Oligoadenylate synthetase in interferon-α- and acyclovir-treated simplex virus-infected cells. J. Interferon Cytokine Res. 15, 27-30.
37. CARLOW, D.A., TEH, S.J., and TEH, H.S. (1998). Specific antiviral activity demonstrated by TGTP, a member of a new family of interferon-induced GTPases. J. Immunol. 161, 2348-2355.
38. HABU, S., AKAMATSU, K.I., TAMAOKI, N., and OKAMURA, K. (1984). In vivo significance of NK cells on resistance against virus (HSV-1) infections in mice. J. Immunol. 133, 2743-2747.
39. RAGER-ZISMAN, B., QUAN, P.C., ROSNER, M., MOLLER J.R., and BLOOM, B.R. (1987). Role of NK cells in protection of mice against herpes simplex virus-1 infection. J. Immunol. 138, 884-888.